Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-6 (IGHV3-6) is classified as a pseudogene within the immunoglobulin heavy variable gene family, located in the human IGH locus on chromosome 14q32.33[3][6]. Pseudogenes in this region are non-functional gene segments that do not encode a protein product and are not involved in the generation of antibody diversity or immune receptor structure in humans[3][4]. They arise through gene duplication or mutation events and are characterized by features such as premature stop codons or frame-shift mutations, which prevent their expression as functional immunoglobulin variable regions. As IGHV3-6 is a pseudogene, it plays no direct biological or therapeutic role and is not considered a druggable or therapeutic target[3][6][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-6 (pseudogene) (IGHV3-6).